Product
Lucinactant
2 clinical trials
4 indications
Indication
COVID-19Indication
Respiratory Distress SyndromeIndication
NewbornClinical trial
A Multicenter, Single-Treatment Study to Assess the Safety and Tolerability of Lyophilized Lucinactant in Adults With COVID-19 Associated Acute Lung InjuryStatus: Completed, Estimated PCD: 2022-02-20
Clinical trial
A Multinational, Multicenter, Masked, Randomized, Controlled Study to Assess the Safety and Efficacy of Lucinactant for Inhalation Versus nCPAP Alone in Preterm Neonates 26 to 32 Weeks Gestational Age With RDSStatus: Terminated, Estimated PCD: 2021-01-31